Industry / India
Ranbaxy Posts Record Annual Financial Results
January 2008 | Company Finance AlertIndian drugmaker Ranbaxy Laboratories has posted record annual financial results after strong sales in both developed and emerging markets. Revenue increased by 9.4% to US$1.69bn and profit rose by a very impressive 53.3% to US$201mn. BMI expects continued success for Ranbaxy in 2008 and beyond as the company consolidates its position and looks for new opportunities to drive growth.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
